Bisphosphonates-Osteonecrosis of Jaw
The recent recognition of bisphosphonate use came into use for pathological conditions which includes osteonecrosis of the jaw (ONJ) and other bone diseases. This article highlights about bisphosphonate and its effect and affect on ONJ. Jaw necrosis is a complication associated with conditions such...
Gespeichert in:
| Veröffentlicht in: | Systematic Reviews in Pharmacy 2014-01, Vol.5 (1), p.1-3 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Systematic Reviews in Pharmacy |
| container_volume | 5 |
| creator | X, Aesha Tanveer, Shahela X, Sreeja |
| description | The recent recognition of bisphosphonate use came into use for pathological conditions which includes osteonecrosis of the jaw (ONJ) and other bone diseases. This article highlights about bisphosphonate and its effect and affect on ONJ. Jaw necrosis is a complication associated with conditions such as radiotherapy, severe fungal or bacterial infections, and sarcoidosis or after intravenous bisphosphonate therapy. The intravenous bisphosphonates - pamidronate (Aredia) and zoledronic acid (Zometa), are often used to treat cancer-related hypercalcemia, Paget's disease, symptoms from solid tumor bone metastasis and osteolytic lesions of multiple myeloma. Bisphosphonate related ONJ has been reported since 2003, in patients taking the drug, more often after dental procedures like extractions, minor surgeries, etc. |
| doi_str_mv | 10.5530/srp.2014.1.1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1855132887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4292720351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c135t-e9b4b6d487863d845c4f5bdd6889064f020452751712c5e980a54d5b6839f413</originalsourceid><addsrcrecordid>eNpNkM1Lw0AQxRdRsLS9-QcU9GjSmexOsnvUYv2g0EvvSz52MUWzcSdF_O9NqAcHhpnD473HT4gbhJRIwppjn2aAKsUUL8QMTEGJViQv__3XYsl8hHGkUYA0E3ePLffvYdquHBwnex5c6FwdA7e8Cn71Vn4vxJUvP9gt_-5cHLZPh81Lsts_v24edkmNkobEmUpVeaN0oXPZjHm18lQ1Ta61gVx5yEBRVhAWmNXkjIaSVENVrqXxCuVc3J5t-xi-To4Hewyn2I2JFjURykzrYlTdn1VTRY7O2z62n2X8sQh2ImFHEnYiYdGi_AXtnE6x</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1855132887</pqid></control><display><type>article</type><title>Bisphosphonates-Osteonecrosis of Jaw</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>X, Aesha ; Tanveer, Shahela ; X, Sreeja</creator><creatorcontrib>X, Aesha ; Tanveer, Shahela ; X, Sreeja</creatorcontrib><description>The recent recognition of bisphosphonate use came into use for pathological conditions which includes osteonecrosis of the jaw (ONJ) and other bone diseases. This article highlights about bisphosphonate and its effect and affect on ONJ. Jaw necrosis is a complication associated with conditions such as radiotherapy, severe fungal or bacterial infections, and sarcoidosis or after intravenous bisphosphonate therapy. The intravenous bisphosphonates - pamidronate (Aredia) and zoledronic acid (Zometa), are often used to treat cancer-related hypercalcemia, Paget's disease, symptoms from solid tumor bone metastasis and osteolytic lesions of multiple myeloma. Bisphosphonate related ONJ has been reported since 2003, in patients taking the drug, more often after dental procedures like extractions, minor surgeries, etc.</description><identifier>ISSN: 0975-8453</identifier><identifier>EISSN: 0975-8453</identifier><identifier>EISSN: 0976-2779</identifier><identifier>DOI: 10.5530/srp.2014.1.1</identifier><language>eng</language><publisher>Perak: Advanced Scientific Research</publisher><subject>19th century ; Antibiotics ; Bacterial infections ; Bone diseases ; Cancer ; Disease prevention ; Gangrene ; Medical imaging ; Metastasis ; Multiple myeloma ; Nitrogen ; NMR ; Nuclear magnetic resonance ; Patients</subject><ispartof>Systematic Reviews in Pharmacy, 2014-01, Vol.5 (1), p.1-3</ispartof><rights>Copyright Phcog.net Jan-Dec 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>X, Aesha</creatorcontrib><creatorcontrib>Tanveer, Shahela</creatorcontrib><creatorcontrib>X, Sreeja</creatorcontrib><title>Bisphosphonates-Osteonecrosis of Jaw</title><title>Systematic Reviews in Pharmacy</title><description>The recent recognition of bisphosphonate use came into use for pathological conditions which includes osteonecrosis of the jaw (ONJ) and other bone diseases. This article highlights about bisphosphonate and its effect and affect on ONJ. Jaw necrosis is a complication associated with conditions such as radiotherapy, severe fungal or bacterial infections, and sarcoidosis or after intravenous bisphosphonate therapy. The intravenous bisphosphonates - pamidronate (Aredia) and zoledronic acid (Zometa), are often used to treat cancer-related hypercalcemia, Paget's disease, symptoms from solid tumor bone metastasis and osteolytic lesions of multiple myeloma. Bisphosphonate related ONJ has been reported since 2003, in patients taking the drug, more often after dental procedures like extractions, minor surgeries, etc.</description><subject>19th century</subject><subject>Antibiotics</subject><subject>Bacterial infections</subject><subject>Bone diseases</subject><subject>Cancer</subject><subject>Disease prevention</subject><subject>Gangrene</subject><subject>Medical imaging</subject><subject>Metastasis</subject><subject>Multiple myeloma</subject><subject>Nitrogen</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Patients</subject><issn>0975-8453</issn><issn>0975-8453</issn><issn>0976-2779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpNkM1Lw0AQxRdRsLS9-QcU9GjSmexOsnvUYv2g0EvvSz52MUWzcSdF_O9NqAcHhpnD473HT4gbhJRIwppjn2aAKsUUL8QMTEGJViQv__3XYsl8hHGkUYA0E3ePLffvYdquHBwnex5c6FwdA7e8Cn71Vn4vxJUvP9gt_-5cHLZPh81Lsts_v24edkmNkobEmUpVeaN0oXPZjHm18lQ1Ta61gVx5yEBRVhAWmNXkjIaSVENVrqXxCuVc3J5t-xi-To4Hewyn2I2JFjURykzrYlTdn1VTRY7O2z62n2X8sQh2ImFHEnYiYdGi_AXtnE6x</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>X, Aesha</creator><creator>Tanveer, Shahela</creator><creator>X, Sreeja</creator><general>Advanced Scientific Research</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140101</creationdate><title>Bisphosphonates-Osteonecrosis of Jaw</title><author>X, Aesha ; Tanveer, Shahela ; X, Sreeja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c135t-e9b4b6d487863d845c4f5bdd6889064f020452751712c5e980a54d5b6839f413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>19th century</topic><topic>Antibiotics</topic><topic>Bacterial infections</topic><topic>Bone diseases</topic><topic>Cancer</topic><topic>Disease prevention</topic><topic>Gangrene</topic><topic>Medical imaging</topic><topic>Metastasis</topic><topic>Multiple myeloma</topic><topic>Nitrogen</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>X, Aesha</creatorcontrib><creatorcontrib>Tanveer, Shahela</creatorcontrib><creatorcontrib>X, Sreeja</creatorcontrib><collection>CrossRef</collection><jtitle>Systematic Reviews in Pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>X, Aesha</au><au>Tanveer, Shahela</au><au>X, Sreeja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bisphosphonates-Osteonecrosis of Jaw</atitle><jtitle>Systematic Reviews in Pharmacy</jtitle><date>2014-01-01</date><risdate>2014</risdate><volume>5</volume><issue>1</issue><spage>1</spage><epage>3</epage><pages>1-3</pages><issn>0975-8453</issn><eissn>0975-8453</eissn><eissn>0976-2779</eissn><abstract>The recent recognition of bisphosphonate use came into use for pathological conditions which includes osteonecrosis of the jaw (ONJ) and other bone diseases. This article highlights about bisphosphonate and its effect and affect on ONJ. Jaw necrosis is a complication associated with conditions such as radiotherapy, severe fungal or bacterial infections, and sarcoidosis or after intravenous bisphosphonate therapy. The intravenous bisphosphonates - pamidronate (Aredia) and zoledronic acid (Zometa), are often used to treat cancer-related hypercalcemia, Paget's disease, symptoms from solid tumor bone metastasis and osteolytic lesions of multiple myeloma. Bisphosphonate related ONJ has been reported since 2003, in patients taking the drug, more often after dental procedures like extractions, minor surgeries, etc.</abstract><cop>Perak</cop><pub>Advanced Scientific Research</pub><doi>10.5530/srp.2014.1.1</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0975-8453 |
| ispartof | Systematic Reviews in Pharmacy, 2014-01, Vol.5 (1), p.1-3 |
| issn | 0975-8453 0975-8453 0976-2779 |
| language | eng |
| recordid | cdi_proquest_journals_1855132887 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | 19th century Antibiotics Bacterial infections Bone diseases Cancer Disease prevention Gangrene Medical imaging Metastasis Multiple myeloma Nitrogen NMR Nuclear magnetic resonance Patients |
| title | Bisphosphonates-Osteonecrosis of Jaw |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A00%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bisphosphonates-Osteonecrosis%20of%20Jaw&rft.jtitle=Systematic%20Reviews%20in%20Pharmacy&rft.au=X,%20Aesha&rft.date=2014-01-01&rft.volume=5&rft.issue=1&rft.spage=1&rft.epage=3&rft.pages=1-3&rft.issn=0975-8453&rft.eissn=0975-8453&rft_id=info:doi/10.5530/srp.2014.1.1&rft_dat=%3Cproquest_cross%3E4292720351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1855132887&rft_id=info:pmid/&rfr_iscdi=true |